Welltower files prospectus supplements for possible share issuances

Welltower Inc., a leading Health Care REIT with a market value of $164 billion, recently submitted several prospectus supplements to the Securities and Exchange Commission. These filings revealed the potential issuance of up to 1,648,490 shares of common stock, accompanied by a strong 31% year-to-date return. The company's dividend yield currently stands at 1.41%, having paid consistent dividends for 51 consecutive years.

The largest portion of these potential shares, up to 1,146,886, could be issued if holders of Class A common units of Welltower OP LLC redeem their units. A separate filing addressed the possibility of up to 166,666 shares being allocated to operating partners through the Welltower Fellowship Grant. This grant, established to honor the legacy of Charles T. Munger, would only result in shares being issued if certain conditions related to eligibility, service, and performance are met.

Registration of these shares does not guarantee their issuance, as it remains to be seen if holders will exercise their exchange or redemption rights. Despite this uncertainty, Welltower's filing also included legal and tax opinions from Gibson, Dunn & Crutcher LLP. The company's third-quarter earnings report showed mixed results, with earnings per share of $0.54 falling short of analyst expectations of $0.65.

However, revenue of $3.72 billion exceeded forecasts of $3.66 billion, and the funds from operations grew by 25%, exceeding the previous quarter's performance. Welltower raised its full-year funds from operations outlook to $6.50 per share. UBS maintained a Buy rating for Welltower, with a price target of $269.00. The senior housing division showed impressive growth, maintaining an income margin above 20%. Nevertheless, the market reacted negatively to the earnings miss.